scholarly journals Two-year follow-up study of a group-based diabetes medical nutrition therapy and motivational interviewing intervention among African American women

2017 ◽  
Vol Volume 8 ◽  
pp. 57-61 ◽  
Author(s):  
Stephania Miller ◽  
Sylvie Akohoue
Keyword(s):  
African American ◽  
Motivational Interviewing ◽  
African American Women ◽  
Nutrition Therapy ◽  
Medical Nutrition Therapy ◽  
American Women ◽  
Follow Up Study ◽  
Medical Nutrition

scholarly journals A Follow-Up Study of Physical Activity and Incidence of Colorectal Polyps in African-American Women

2006 ◽  
Vol 163 (suppl_11) ◽  
pp. S72-S72
Author(s):  
L Rosenberg ◽  
D Boggs ◽  
L.A Wise ◽  
J.R Palmer ◽  
M.H Roltsch ◽  
...  
Keyword(s):  
Physical Activity ◽  
African American ◽  
African American Women ◽  
Colorectal Polyps ◽  
American Women ◽  
Follow Up Study

Celiac Disease

2021 ◽  
pp. 93-114
Author(s):  
Haalah M. Shaaker
Keyword(s):  
Celiac Disease ◽  
Autoimmune Disorder ◽  
Nutrition Therapy ◽  
Medical Nutrition Therapy ◽  
Nutrient Supplements ◽  
Proximal Small Intestine ◽  
Packaged Foods ◽  
Medical Nutrition

This chapter reveals and discusses a case involving celiac disease (CD). CD is a common, lifelong, genetically-based autoimmune disorder that causes inflammation of the proximal small intestine. This disease is triggered by eating foods containing gluten, which causes intestinal discomfort. Gluten is a protein that is found naturally in wheat, barley, and rye and is common in foods such as bread, pasta, cookies, and cakes. Many pre-packaged foods, lip balms and lipsticks, hair and skin products, toothpaste and vitamin and nutrient supplements contain gluten, although it is rarely found in medicine. The key to living with CD is to follow a gluten-free diet. This case shows the role of medical nutrition therapy in managing and preventing the undesirable symptoms of CD. Moreover, it allows dietetic professionals to assess celiac patients' conditions and provide them with relief from undesirable symptoms, while also establishing an effective follow-up plan with each patient.

scholarly journals Factors Influencing Breast Cancer Genetic Testing Among High Risk African American Women: A Systematic Review

2019 ◽  
Author(s):  
Shirley Spencer ◽  
Carolyn Rodgers ◽  
Vickii Coffey
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
African American ◽  
Genetic Testing ◽  
High Risk ◽  
African American Women ◽  
Integrative Model ◽  
Cancer Genetic ◽  
American Women

African American women are disproportionately impacted by breast cancer and its associated effects. They have the highest breast cancer mortality rate of all racial and ethnic groups in the U.S., yet, many high risk African American women do not follow-up with genetic testing despite, having a shorter survival rate and more likely to develop malignancies or aggressive forms of breast cancer than white women. Purpose: This review explored breast cancer genetic follow up and barriers among African American women and made recommendations for designing tailored high risk breast cancer programs. Method: The Integrative Model of Behavioral Prediction framework provided the framework for the review. PubMed, PSYINFO, CINAHL and Cochrane Collection Plus databases were searched for articles published from 2007 to 2017 that focused on attitude and beliefs that influenced genetic testing follow up among African American women. Three reviewers independently reviewed and appraised articles. The quality of the articles was assessed to determine the evidence level and overall recommendations using the Joanna Bridge Institute grading criteria. Results: Sixteen of the 2275 articles reviewed met the inclusion criteria of which, seven showed statistically significance changes related to family concerns, medical mistrust and cost barriers; decreases in breast cancer worry and perceived risk after genetic counseling; and higher education level and diagnosed early increased genetic testing. Conclusions: This systematic review provides greater understanding of how the social determinants of health influence decisions about genetic testing and treatment to determine why African American women who are at risk for breast cancer, do not progress to genetic testing. It provided recommendations for designing sensitive curriculum content for African American women and providers to increase genetic follow-up and reduce breast cancer disparity. The results of this review could be used to design comprehensive, tailored interventions to address the identified barriers, increase breast cancer awareness and early detection, and help minority women make informed, value decisions about genetic testing and treatment options. Recommendations: Future research is required to examine the role communities, agencies and policy makers play in improving clinical outcomes for minorities.

scholarly journals California Cardiovascular Screening Tool: Findings from Initial Implementation

2020 ◽  
Vol 10 (04) ◽  
pp. e362-e368
Author(s):  
Elizabeth A. Blumenthal ◽  
B. Adam Crosland ◽  
Dana Senderoff ◽  
Kathryn Santurino ◽  
Nisha Garg ◽  
...  
Keyword(s):  
African American ◽  
African American Women ◽  
True Positive Rate ◽  
Postpartum Women ◽  
True Positive ◽  
American Women ◽  
Persistent Symptoms ◽  
Screening Algorithm ◽  
Positive Rate

Abstract Objective American College of Obstetricians and Gynecologists (ACOG) recently published the California (CA) cardiovascular disease (CVD) screening algorithm for pregnant and postpartum women. We aim to prospectively determine screen-positive and true-positive rates of CVD among women across two populations. Study Design This is a prospective cohort study of obstetrical patients from April 2018 to July 2019 at academic medical centers in CA and New York (NY). We attempted to screen all patients at least once during their pregnancy care (prenatal or postpartum). Women who screened positive (“Red Flags,” >3–4 moderate risk factors, abnormal physical examination, and persistent symptoms) underwent further testing. The primary outcome was the screen-positive rate. Secondary outcomes included the true-positive rate and the strength of each moderate factor in predicting a positive CVD screen. Results We screened 846 women. The overall screen-positive rate was 8% (5% in CA vs. 19% in NY). The sites differed in ethnicity, that is, African American women (2.7% in CA vs. 35% in NY, p < 0.01) and substance use (2.7 vs. 5.6%, p < 0.04). The true-positive rate was 1.5% at both sites. The percentage of screen-positive patients who did not complete follow-up studies was higher in NY (70%) than in CA (27%). CVD was confirmed in 30% with positive screens with complete follow-up. Combinations of moderate factors were the main driver of screen-positive rates in both populations. Conclusion This is the first data describing the performance of the CVD screening algorithm in a general obstetric population. Factors, such as proportion of African American women affect the likelihood of a positive screen. The screening algorithm highlights patients at higher lifetime risk of CVD and may identify a group that could be targeted for more direct care transitions postpartum. Data may be used to design a larger validation study.

Sign in / Sign up

Export Citation Format

Share Document